485 research outputs found

    A novel approach for the characterisation of proteoglycans and biosynthetic enzymes in a snail model

    Get PDF
    Proteoglycans encompass a heterogeneous group of glycoconjugates where proteins are substituted with linear, highly negatively charged glycosaminoglycan chains. Sulphated glycosaminoglycans are ubiquitous to the animal kingdom of the Eukarya domain. Information on the distribution and characterisation of proteoglycans in invertebrate tissues is limited and restricted to a few species. By the use of multidimensional protein identification technology and immunohistochemistry, this study shows for the first time the presence and tissue localisation of different proteoglycans, such as perlecan, aggrecan, and heparan sulphate proteoglycan, amongst others, in organs of the gastropoda Achatina fulica. Through a proteomic analysis of Golgi proteins and immunohistochemistry of tissue sections, we detected the machinery involved in glycosaminoglycan biosynthesis, related to polymer formation (polymerases), as well as secondary modifications (sulphation and uronic acid epimerization). Therefore, this work not only identifies both the proteoglycan core proteins and glycosaminoglycan biosynthetic enzymes in invertebrates but also provides a novel method for the study of glycosaminoglycan and proteoglycan evolution. (C) 2011 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)NIHUniversidade Federal de São Paulo, Dept Bioquim, BR-04044020 São Paulo, BrazilUniv Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79912 USAUniversidade Federal de São Paulo, Dept Bioquim, BR-04044020 São Paulo, BrazilNIH: 2G12RR008124-16A1NIH: 2G12RR008124-16A1S1Web of Scienc

    Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

    Get PDF
    The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species. Polyenes, fluoropyrimidines, echinocandins, and azoles are used as commercial antifungal agents to treat candidiasis. However, the presence of intrinsic and developed resistance against azole antifungals has been extensively documented among several Candida species. The advent of original and re-emergence of classical fungal diseases have occurred as a consequence of the development of the antifungal resistance phenomenon. In this way, the development of new satisfactory therapy for fungal diseases persists as a major challenge of present-day medicine. The design of original drugs from traditional medicines provides new promises in the modern clinic. The urgent need includes the development of alternative drugs that are more efficient and tolerant than those traditional already in use. The identification of new substances with potential antifungal effect at low concentrations or in combination is also a possibility. The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species. In addition, this review describes some of the promising alternative molecules and/or substances that could be used as anticandidal agents, their mechanisms of action, and their use in combination with traditional drugs

    Patterns of viral load in chronic hepatitis B

    Get PDF
    ABSTRACT Serum hepatitis B virus (HBV) DNA level is a predictor of the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients. Nevertheless, the distribution of viral load levels in chronic HBV patients in Brazil has yet to be described. This cross-sectional study included 564 participants selected in nine Brazilian cities located in four of the five regions of the country using the database of a medical diagnostics company. Admission criteria included hepatitis B surface antigen seropositivity, availability of HBV viral load samples and age ≥ 18 years. Males comprised 64.5% of the study population. Mean age was 43.7 years. Most individuals (62.1%) were seronegative for the hepatitis B e antigen (HBeAg). Median serum ALT level was 34 U/L. In 58.5% of the patients HBV-DNA levels ranged from 300 to 99,999 copies/mL; however, in 21.6% levels were undetectable. Median HBV-DNA level was 2,351 copies/mL. Over 60% of the patients who tested negative for HBeAg and in whom ALT level was less than 1.5 times the upper limit of the normal range had HBV-DNA levels > 2,000 IU/mL, which has been considered a cut-off point for indicating a liver biopsy and/or treatment. In conclusion, HBV-DNA level identified a significant proportion of Brazilian individuals with chronic hepatitis B at risk of disease progression. Furthermore, this tool enables those individuals with high HBV-DNA levels who are susceptible to disease progression to be identified among patients with normal or slightly elevated ALT

    Relationship arachidonic acid (ARA): docosahexaenoic acid (DHA) in the body composition of Nile tilapia fed with diets containing the microalgae Schizochytrium sp.

    Get PDF
    Todos os textos, informa??es e resultados apresentados s?o de inteira responsabilidade dos autores.Ag?ncias financiadoras para a realiza??o do trabalho: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq), Alltech Inc., Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) e Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (FAPEMIG).O ?cido araquid?nico compete com DHA pelas mesmas vias metab?licas na forma??o de membranas e constitui??o das c?lulas do f?gado. Isto sugere que a ingest?o de DHA podem substituir parcialmente o ?cido araquid?nico atrav?s da modifica??o da composi??o de ?cidos graxos nos tecidos, o que reduz a ocorr?ncia de desordens nos sitema imune e doen?as inflamat?rias. Com isso, objetivou-se avaliar a rela??o ARA : DHA corporal de alevinos de til?pia do Nilo alimentadas com ra??es contendo a microalga Schizochytrium sp..Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq)Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES)Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (FAPEMIG)The arachidonic acid competes with DHA by the same pathways in the formation of membranes and formation of liver cells. This suggests that intake of DHA may partially replace arachidonic acid by modifying the composition of fatty acids in tissues, reducing the occurrence of immune system disorders and inflammatory diseases. The relationship ARA: DHA body of Nile tilapia fry fed diets containing the microalgae Schizochytrium sp. was evaluated
    corecore